MedPath
TGA Approval

ABILIFY MAINTENA aripiprazole (as monohydrate) 300 mg powder and solvent for prolonged release suspension for injection pre-filled syringe (297643)

297643

ABILIFY MAINTENA aripiprazole (as monohydrate) 300 mg powder and solvent for prolonged release suspension for injection pre-filled syringe

Lundbeck Australia Pty Ltd

May 7, 2018

Medicine

Medicine

Active

Registered

Active Ingredients

aripiprazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.